| 前收盘价格 | 0.315 |
| 收盘价格 | 0.315 |
| 成交量 | 291,400 |
| 平均成交量 (3个月) | 503,700 |
| 市值 | 93,199,464 |
| 价格/销量 (P/S) | 1.98 |
| 股市价格/股市净资产 (P/B) | 1.05 |
| 52周波幅 |
| 营业毛利率 | -11.85% |
| 营业利益率 (TTM) | 2.64% |
| 稀释每股收益 (EPS TTM) | -0.020 |
| 季度收入增长率 (YOY) | 85.40% |
| 总债务/股东权益 (D/E MRQ) | 3.92% |
| 流动比率 (MRQ) | 3.03 |
| 营业现金流 (OCF TTM) | 16.99 M |
| 杠杆自由现金流 (LFCF TTM) | -4.86 M |
| 资产报酬率 (ROA TTM) | -4.45% |
| 股东权益报酬率 (ROE TTM) | -6.60% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Medical Instruments & Supplies (MY) | 混合的 | 混合的 |
| Medical Instruments & Supplies (全球的) | 混合的 | 混合的 | |
| 股票 | ADVENTA | - | - |
AIStockmoo 评分
-0.4
| 分析师共识 | 0.0 |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | 0.5 |
| 平均 | -0.38 |
|
Adventa Bhd is engaged in the business of medical services and related supplies manufacturing. The company's segments include Healthcare Business, Warehousing provider, and Corporate. It generates maximum revenue from the Healthcare Business segment. The healthcare business segment comprises the supply of healthcare and related products and services to hospitals, healthcare centers, and pharmacies. Previously, it also included the renal dialysis business which is both for home and center-based treatments, serving both the domestic and export markets. Geographically, it derives a majority of its revenue from Malaysia. |
|
| 部门 | Healthcare |
| 行业 | Medical Instruments & Supplies |
| 投资方式 | Small Value |
| 内部持股比例 | 71.46% |
该时间范围内无数据。
该时间范围内无数据。
| 除息日 | 公告日期 | 支付日期 | 详情 |
|---|---|---|---|
| 14 Jan 2020 | 30 Dec 2019 | 22 Jan 2020 | 0.07 现金 |
每年股息收益率
| 年份 | 每年总股息 ($) | 频率/年份 | 收益率 % |
|---|---|---|---|
| 2020 | 0.070 | 1 | 4.58 |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合